SREBF1 and fatty liver disease: In particular, alcohol and/or acetaldehyde can inhibit the phosphorylation of AMP-activated protein kinase (AMPK) and increase the expression of sterol regulatory element-binding proteins-1 (SREBP-1), resulting in an imbalance in lipid metabolism, ultimately contributing to the development of hepatic steatosis [4,5].